ArticlePeerJ2026
Research of the lipoprotein combined index and its association with osteoporosis in elderly Chinese adults: a retrospective cross-sectional study.
Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to investigate the relationship between the lipoprotein combined index (LCI) and osteoporosis (OP) risk in elderly Chinese individuals. Methods: This retrospective cross-sectional study included 7,383 participants aged 60 years and older who underwent chest computed tomography (CT) with quantitative CT (QCT) at the First Affiliated Hospital of the University of Science and Technology of China, Hefei, from January 2023 to June 2025. Participants were categorized into non-osteoporosis (non-OP) and osteoporosis (OP) groups based on lumbar spine bone mineral density (BMD), with BMD thresholds set at ≥ 80 mg/cm Results: LCI levels were significantly lower in the OP group compared to the non-OP group ( Conclusion: Higher LCI levels are independently linked to a reduced risk of OP in older adults, particularly when LCI ≥ 18. LCI may serve as a potential biomarker reflecting the role of lipid metabolism in OP.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.